List of OncoAnalytics Customers
New York, 10013, NY,
United States
Since 2010, our global team of researchers has been studying OncoAnalytics customers around the world, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Each quarter our research team identifies companies that have purchased OncoAnalytics for Clinical Trial Management from public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources, including the customer size, industry, location, implementation status, partner involvement, LOB Key Stakeholders and related IT decision-makers contact details.
Companies using OncoAnalytics for Clinical Trial Management include: West Cancer Center & Research Institute, a United States based Healthcare organisation with 694 employees and revenues of $150.0 million, Dayton Physicians Network, a United States based Healthcare organisation with 350 employees and revenues of $42.0 million, Virginia Cancer Institute, a United States based Healthcare organisation with 300 employees and revenues of $25.0 million and many others.
Contact us if you need a completed and verified list of companies using OncoAnalytics, including the breakdown by industry (21 Verticals), Geography (Region, Country, State, City), Company Size (Revenue, Employees, Asset) and related IT Decision Makers, Key Stakeholders, business and technology executives responsible for the software purchases.
The OncoAnalytics customer wins are being incorporated in our Enterprise Applications Buyer Insight and Technographics Customer Database which has over 100 data fields that detail company usage of software systems and their digital transformation initiatives. Apps Run The World wants to become your No. 1 technographic data source!
Apply Filters For Customers
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | SI | Insight |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Dayton Physicians Network | Healthcare | 350 | $42M | United States | Flatiron | OncoAnalytics | Clinical Trial Management | 2018 | n/a |
In 2018, Dayton Physicians Network expanded its relationship with Flatiron and continued deployment of OncoAnalytics as part of a broader Clinical Trial Management initiative. The implementation was explicitly focused on clinical research and clinical trials, and it supported value based care reporting for Oncology Care Model and MIPS across the organization’s U.S. network.
OncoAnalytics was configured to provide centralized clinical operations reporting and analytics, supporting trial portfolio oversight, patient enrollment tracking, study workflow orchestration, and outcomes reporting for quality programs. The work included co-deployment alongside Flatiron OncoEMR and OncoTrials, and the Oncology Care Model services were used to align clinical data with value based care metric reporting.
Operational coverage targeted oncology clinics and clinical research functions across Dayton Physicians Network’s U.S. sites, with data flows coordinated between OncoEMR, OncoTrials and OncoAnalytics to reconcile clinical encounter data, study eligibility and trial enrollment records, and OCM/MIPS quality measures. Integrations remained within the Flatiron application suite to enable a unified Clinical Trial Management and reporting stack for oncology research and value based care.
Governance emphasized centralized reporting, standardized trial intake and study governance workflows to support expansion of the trials network. The stated outcomes of the implementation were to grow the organization’s clinical trials network and to improve operational efficiency in clinical research and value based care reporting.
|
|
|
Virginia Cancer Institute | Healthcare | 300 | $25M | United States | Flatiron | OncoAnalytics | Clinical Trial Management | 2016 | n/a |
In 2016, Virginia Cancer Institute implemented Flatiron OncoAnalytics within its Clinical Trial Management environment. The deployment was designed to support clinical operations and clinical research across the United States, providing analytics-driven insights intended to improve the quality and value of oncology care. OncoAnalytics was deployed in concert with Flatiron OncoEMR, creating an integrated analytics and clinical data workflow to inform practice management and care delivery.
Implementation emphasized analytics and reporting capabilities, with OncoAnalytics ingesting clinical data and surfacing patient-level and operational intelligence for clinicians and research staff. Functional coverage focused on clinical operations workflows, clinical research support, and practice management reporting, using OncoAnalytics to centralize business and clinical intelligence. Governance and rollout centered on aligning analytics outputs with clinical and research team processes, embedding insights into operational decision making and practice management routines.
|
 |
West Cancer Center & Research Institute | Healthcare | 694 | $150M | United States | Flatiron | OncoAnalytics | Clinical Trial Management | 2016 | n/a |
In 2016, West Cancer Center & Research Institute implemented Flatiron's OncoAnalytics, a Clinical Trial Management application. The center selected OncoEMR alongside OncoAnalytics to enhance evidence-based care and to support participation in alternative payment models.
OncoAnalytics was deployed to provide analytics-driven cohort identification, trial matching and study feasibility insight consistent with Clinical Trial Management capabilities. The deployment emphasized operational dashboards and enrollment tracking to support management of Phase I through Phase III studies across its US sites, with functional configuration focused on clinical trial workflow orchestration, protocol adherence monitoring and study portfolio visibility.
Integration with Flatiron OncoEMR aligned clinical documentation with trial eligibility signals and operational reporting across clinical operations and clinical trials. Governance changes centered on standardizing trial intake and enrollment workflows and on embedding analytics-driven decision support to support access to studies and alternative payment model participation, with the stated aim of improving operational efficiency and broadening access to Phase I–III studies.
|
Buyer Intent: Companies Evaluating OncoAnalytics
Discover Software Buyers actively Evaluating Enterprise Applications
| Logo | Company | Industry | Employees | Revenue | Country | Evaluated | ||
|---|---|---|---|---|---|---|---|---|
| No data found | ||||||||